Data / Form D filings / REGENESIS BIOMEDICAL INC
REGENESIS BIOMEDICAL INC: Form D filing
REGENESIS BIOMEDICAL INC, a biotechnology company in Scottsdale, AZ, filed a Form D with the SEC in 2011. The latest, on June 21, 2011, reports $5.2 million sold of an offering with no set size to 9 investors.
Find out what REGENESIS BIOMEDICAL INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1435 NORTH HAYDEN ROAD, Scottsdale, AZ, 85257
- Phone
- 18779704970
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1172973
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 21, 2011 | New notice | Indefinite | $5,202,364 | Indefinite | 9 | Jun 2, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CHUCK LUNDEN | Director | |
| VIRGINIA RYBSKI | Executive Officer, Director | |
| JOHN VORIS | Director | |
| HENRY NEWMAN | Director | |
| JACK AHRENS | Director | |
| PETER SHEEHAN | Director | |
| TOM GREER | Director | |
| DENNIS GENGE | Executive Officer |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Jun 20, 2011 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what REGENESIS BIOMEDICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.